Acrivon Therapeutics is Biotechnology in United States that focus on operator business. Founded in 2018. They cover business area such as operator, license clinical-stage asset, a pipeline, internally develop program, technology platform, toxicity, chemical design, in-license drug, patient, predictive phosphoproteomic, artificial intelligence, physician, failure.
2018
( 6 years old in 2024 )
Operator
-
480 Arsenal Way
Suite 100
Watertown, MA 02472
United States
Private
operatorlicense clinical-stage asseta pipelineinternally develop programtechnology platformtoxicitychemical designin-license drugpatientpredictive phosphoproteomicartificial intelligencephysicianfailure
* We use standard office opening hours in near Acrivon Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Acrivon Therapeutics is Biotechnology business from United States that founded in 2018 (6 years old in 2024), Acrivon Therapeutics business is focusing on Operator.
Acrivon Therapeutics headquarter office and corporate office address is located in 480 Arsenal Way Suite 100 Watertown, MA 02472 United States.
Acrivon Therapeutics was founded in United States.
In 2024, Acrivon Therapeutics is currently focus on operator sector.
Above is snippet of Google Trends for "operator" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Acrivon Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
